GT719 Injection for Moderate to Severe Refractory Autoimmune Disease

Clinical trial NCT07132112 · RECRUITING

Trial details

NCT number: NCT07132112
Sponsor: Grit Biotechnology
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Auto Immune Disease

Start date: 2025-10-28
Primary completion: 2028-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.